Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Feb 18;94(4):1074-9.
doi: 10.1073/pnas.94.4.1074.

Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300

Affiliations

Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300

A E Horvai et al. Proc Natl Acad Sci U S A. .

Abstract

We report that interferon gamma (IFN-gamma) inhibits transcription of the macrophage scavenger receptor gene by antagonizing the Ras-dependent activities of AP-1 and cooperating ets domain transcription factors, apparently as a result of competition between AP-1/ets factors and activated STAT1 for limiting amounts of CBP and p300. Consistent with this model, STAT1 alpha interacts directly with CBP in cells, and microinjection of anti-CBP and anti-p300 antibodies blocks transcriptional responses to IFN-gamma. Cells lacking STAT1 fail to inhibit AP-1/ets activity, and overexpression of CBP both potentiates IFN-gamma-dependent transcription and relieves AP-1/ets repression. Thus, CBP and p300 integrate both positive and negative effects of IFN-gamma on gene expression by serving as essential coactivators of STAT1 alpha, modulating gene-specific responses to simultaneous activation of two or more signal transduction pathways.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IFN-γ antagonizes M-CSF-dependent expression of scavenger receptor hGH transgenes. (A) SR–hGH fusion genes used to generate transgenic mice are illustrated, indicating the approximate positions of binding sites for AP-1, ets2, and PU.1 proteins. SRmAE–hGH contains point mutations in the AP-1/ets binding motifs that abolish AP-1 and ets2 interaction. (B) Regulation of the SR6.5-hGH, SR-EP–hGH, and SRmAE–hGH transgenes in bone marrow progenitor cells and progenitor cells treated for 3 days with M-CSF (20 ng/ml). (C) IFN-γ inhibition of M-CSF-dependent expression of SR6.5-hGH and SRmEP–hGH transgenes in bone-marrow-derived macrophages. (D) Inhibition of TPA-dependent expression of SR6.5–luciferase and SR-EP–luciferase fusion genes in THP-1 cells. The SR6.5 and SR-EP regulatory elements illustrated in A were fused to a luciferase reporter gene and transfected into THP-1 cells. Cells were treated with TPA and/or IFN-γ, and luciferase activity was quantitated 12 hr later. (E) IFN-γ inhibits TPA and Val-12 Ras-dependent activation of an AP-1/ets-dependent promoter. A luciferase reporter gene containing three copies of the composite AP-1/ets element from the SR-A promoter fused to the minimal (−36 to +33) rat prolactin promoter was transfected into HeLa cells. To stimulate AP-1 and ets activity, cells were either cotransfected with a vector directing the expression of a constitutively active form of Ras (Val-12 Ras) or treated with TPA.
Figure 2
Figure 2
IFN-γ inhibits the transcriptional activities of AP-1 and cooperating ets factors. (A) IFN-γ inhibits the activities of the c-jun transactivation domain. The N-terminal transactivation domain of c-jun was fused in frame to the GAL4 DNA binding domain and used to direct expression of a Gal4-dependent promoter. Transactivation domain function was stimulated by cotransfection of a Val-12 Ras expression plasmid. (B) Effects of IFN-γ on c-Jun kinase and ets2 kinase activities. HeLa cells were rendered quiescent by culture in serum-free media for 16 hr and then treated with IFN-γ, TPA, and/or serum as indicated. Cell lysates were then assayed for Jun N-terminal kinase and ets2 kinase activities (24). (C) Overexpression of CBP relieves IFN-γ antagonism of AP-1/ets activities. The 3× AP-1/ets-promoter was cotransfected into THP-1 cells with 1 μg of a CBP expression plasmid or an equivalent amount of empty expression plasmid and treated with IFN-γ and/or TPA. (D) Overexpression of CBP potentiates transcriptional responses to IFN-γ. A luciferase reporter gene containing eight GASs linked to a minimal prolactin promoter was cotransfected into HeLa cells with increasing amounts of a vector directing expression of CBP (24). Error bars for A, C, and D are standard deviations.
Figure 3
Figure 3
CBP and p300 are required for IFN-γ-dependent transcription. (A) Microinjection of a CBP-specific antiserum inhibits IFN-γ-dependent transcription. Rat-1 fibroblasts were injected with a lacZ reporter gene under the transcriptional control of a minimal promoter containing eight copies of a consensus GAS. Cells were co-injected with control rabbit IgG (1, 2, 4, 5) or rabbit anti-CBP IgG (3, 6), treated with vehicle (1, 4) or IFN-γ (2, 3, 5, 6), and analyzed 12 hr later. Expression of the lacZ reporter gene was determined by 5-bromo-4-chloro-3-indolyl β-d-galactoside (X-Gal) staining (–6). Injected cells were visualized by nuclear staining for IgG using a rhodamine anti-rabbit IgG (1, 2, 3) and by the presence of X-Gal staining, which partially quenches the rhodamine signal. Photomicrographs of representative injected cells are shown. (B) Co-injection of anti-CBP and anti-p300 IgG strongly inhibits IFN-γ-dependent transcription. Cells were injected with the GAS–lacZ reporter gene and anti-CBP IgG, anti-CBP preincubated with the CBP peptide antigen, anti-p300 IgG, or a combination of anti-CBP IgG and anti-p300 IgG as shown. The bar graph indicates the percentage of injected cells that exhibited detectable X-Gal staining. (C) Injection of anti-p300 IgG has no effect on basal levels of expression of a SP1-dependent (SV40)–lacZ reporter gene. For B and C, error bars represent the mean ± SEM of a minimum of three experiments in which at least 200 cells were injected.
Figure 4
Figure 4
Interactions of STAT1α with CBP (A) STAT1α interacts with CBP in cells. 293 cells were transfected with a vector directing expression of an epitope (FLAG)-tagged form of CBP and then treated with IFN-γ or vehicle for 15 min, and whole-cell lysates were prepared. Lysates were immunoprecipitated with an anti-STAT1 antiserum (lanes 2 and 3) or preimmune serum (lane 4). Immunoprecipitates or unprecipitated lysate (lane 1) were resolved by SDS/PAGE, transferred to nitrocellulose membranes, and subjected to Western blotting using an anti-CBP antiserum. (B) IFN-γ-dependent interactions of STAT1α with the N terminus of CBP. The indicated regions of CBP were linked in frame to the DNA binding domain of GAL4 and transfected into 293 cells. Cells were subsequently treated with IFN-γ or vehicle for 15 min, and whole-cell lysates were prepared. Lysates were immunoprecipitated with an anti-STAT1 antiserum and subjected to Western blotting using an anti-GAL4 DNA binding domain antibody. (C) Direct interactions of STAT1α with the N terminus of CBP. 35S-labeled STAT1α or STAT1ΔC truncated at amino acid 705 were produced by translation in vitro and incubated with GST–CBP1–451, GST–CBP-bromo domain, or GST alone. After washing and SDS/PAGE, specifically associated proteins were detected by autoradiography.
Figure 5
Figure 5
AP-1/ets inhibition requires STAT1. The luciferase reporter gene containing three copies of the composite AP-1/ets element described in Fig. 1E was transfected into U3A cells that lack STAT1 or parental 2fTGH cells that contain functional STAT1. Cells were treated with TPA and/or IFN-γ, as indicated, before assay for relative luciferase activity. Error bars are standard deviations

References

    1. Young H A, Hardy K J. J Leukocyte Biol. 1995;58:373–381. - PubMed
    1. Schindler C, Darnell J E J. Annu Rev Biochem. 1995;64:621–651. - PubMed
    1. Pearse R N, Feinman R, Shuai K, Darnell J E, Jr, Ravetch J V. Proc Natl Acad Sci USA. 1993;90:4314–4318. - PMC - PubMed
    1. Müller M, Laxton C, Briscoe J, Schindler C, Improta T, Darnell J E J, Stark G R, Kerr I M. EMBO J. 1993;12:4221–4228. - PMC - PubMed
    1. Shuai K, Horvath C M, Huang L H, Qureshi S A, Cowburn D, Darnell J E., Jr Cell. 1994;76:821–828. - PubMed

Publication types

MeSH terms

Substances